Covered recipient · General Payments record
JOSEPH A GILLESPIE
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$2,298.73
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.84 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UROGEN PHARMA, INC. | $125.56 | 4 |
| Janssen Biotech, Inc. | $46.09 | 2 |
| Sumitomo Pharma America, Inc. | $39.94 | 2 |
| PFIZER INC. | $35.43 | 2 |
| TOLMAR, INC. | $23.74 | 1 |
| Merck Sharp & Dohme Corporation | $22.17 | 1 |
| Axonics Modulation Technologies, Inc. | $19.29 | 1 |
| Antares Pharma, Inc. | $16.38 | 1 |
| IMMUNITYBIO, INC. | $15.17 | 1 |
| Teleflex LLC | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Antares Pharma, Inc. | $16.38 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146459949 | CMS |
| Axonics, Inc. | $19.29 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142372860 | CMS |
| IMMUNITYBIO, INC. | $15.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125508786 | CMS |
| Janssen Biotech, Inc. | $21.18 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078627275 | CMS |
| Janssen Biotech, Inc. | $24.91 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078627549 | CMS |
| Merck Sharp & Dohme LLC | $22.17 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141654443 | CMS |
| PFIZER INC. | $18.38 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130924717 | CMS |
| PFIZER INC. | $17.05 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131240692 | CMS |
| Sumitomo Pharma America, Inc. | $23.96 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148856057 | CMS |
| Sumitomo Pharma America, Inc. | $15.98 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148856059 | CMS |
| Teleflex LLC | $13.07 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142070031 | CMS |
| Tolmar, Inc. | $23.74 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138708105 | CMS |
| UROGEN PHARMA, INC. | $27.66 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137933214 | CMS |
| UROGEN PHARMA, INC. | $28.97 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137925590 | CMS |
| UROGEN PHARMA, INC. | $36.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137931804 | CMS |
| UROGEN PHARMA, INC. | $32.93 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137930338 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.